Argentina's ANMAT simplifies regulatory approval process for medication modifications

Argentina's drug regulatory agency, ANMAT, has streamlined the approval process for modifications to already authorized medications to reduce bureaucratic delays. The new policy allows for the integration of evaluations conducted by foreign regulatory bodies, potentially accelerating domestic market access for updated pharmaceutical products.